INS and thyroid cancer: These anticancer effects are thought to be mediated through interference with insulin/IGF signalling and modulation of the AMPK/mTOR pathway, which inhibits unchecked cell cycle progression, induces apoptosis in thyroid cancer cells, and reduces colony formation and migration [37].